The effect of a dual or a triple antithrombotic therapy with apixaban on thrombus formation in vivo and in an ex vivo perfusion chamber model: An open-label, controlled, sequential study

BACKGROUND: There is a need to optimize pharmacological treatment in patients with acute coronary syndrome and concomitant atrial fibrillation, in particular with newer antithrombotic medicines. We have therefore studied if dual or triple combination of antithrombotic agents exert similar effects on...

Descripción completa

Detalles Bibliográficos
Autores principales: Weisshaar, Stefan, Litschauer, Brigitte, Bucher, Sebastian, Riesenhuber, Martin, Kapiotis, Stylianos, Kyrle, Paul Alexander, Wolzt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058860/
https://www.ncbi.nlm.nih.gov/pubmed/27399131
http://dx.doi.org/10.1097/MD.0000000000004145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058860/
https://www.ncbi.nlm.nih.gov/pubmed/27399131
http://dx.doi.org/10.1097/MD.0000000000004145

Ejemplares similares